Peritoneal carcinomatosis or peritoneal metastasis is a stage of advanced cancer that occurs when cancer cells spread through the peritoneum, the membrane that lines the abdominal cavity and the abdominal internal organs.
Cytoreduction surgery and hipec
Cytoreductive surgery is a comprehensive surgery to remove as many tumor nodules as possible from the peritoneum. It consists of a combination of peritonectomy techniques (removal of the peritoneum) and other organs to remove all visible disease from the abdomen.
HIPEC consists of the administration of chemotherapy at a temperature between 40-43°C for a specific time, between 60-120 minutes, at the end of the cytoreduction surgery procedure. The objective is to eliminate microscopic disease and possible tumor cells that may be free in the abdomen after cytoreduction surgery.
PIPAC is a treatment indicated for patients with cancer with abdominal dissemination, who are not candidates for treatment with HIPEC and cytoreduction. Applying the chemotherapy as an aerosol or spray and with pressure, improves penetration into the tumor nodules, without the chemotherapy passing into the blood (or a minimal amount).
To the aerosolized and pressurized chemotherapy is added the latest ePIPAC technology, which consists of adding electrostatic precipitation to increase the penetration of the chemotherapy into the tumor nodules and improve the distribution of the chemotherapy inside the abdomen.
Palliative care is an important part of the treatment of peritoneal carcinomatosis. They can help relieve pain and other symptoms of the disease.
These approaches have markedly improved the prognosis and quality of life of patients with peritoneal carcinomatosis. The Viamed Institute of Advanced Surgical Oncology (IVOQA) has established itself as a leader in personalized, minimally invasive treatments for this complex disease.
The combination between systemic chemotherapy, intraperitoneal chemotherapy and surgery has improved the prognosis of peritoneal carcinomatosis in the last decades.
The Viamed Institute of Advanced Surgical Oncology (IVOQA) has established itself as a benchmark in the comprehensive and personalized treatment of cancer patients, using minimally invasive techniques.
